Skip to main content
. 2021 Nov 9;13(11):1901. doi: 10.3390/pharmaceutics13111901

Table 1.

Inorganic-based miRNA delivery systems.

Delivery System miRNA Therapeutic
Application
Particle Size Refs.
Gold-iron oxide NPs anti-miR-21
miR-100
Glioblastoma 10–50 nm [47]
Gold NPs miR-21 Cancer 61.3 nm [55]
Gold NPs miR-34a
miR-200a
let7-a
Cancer 2 nm [56]
Silica NPs miR-34a Neuroblastoma N/A [44]
Silica dioxide NPs miR-34a Breast cancer 12–18 nm [53]

N/A: not applicable.